23 Results for "

VWF

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "VWF" in MCE Product Catalog:

1
1 Cited Publications
Art. -Nr.: HY-P99227
CAS. Nr.: 915810-67-2
Synonyms: ALX-0681; ALX-0081

Forschungsgebiete:  

Cardiovascular Disease

Caplacizumab (His Tag) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab (His Tag) inhibits the binding of vWF with platelet glycoprotein (GP) Ibα. Caplacizumab (His Tag) inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab (His Tag) can be used for the research of thrombotic thrombocytopenic purpura (TTP) .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P5354
Target:  

Fluorescent Dye

Forschungsgebiete:  

Cardiovascular Disease

FRETS-VWF73, a 73-amino-acid peptide, is a fluorogenic substrate for ADAMTS13 assay (Ex = 340 nm; Em = 450 nm). FRETS-VWF73 is a predictive tool for thrombotic thrombocytopenic purpura .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P5354A
Target:  

Fluorescent Dye

Forschungsgebiete:  

Others

FRETS-VWF73 TFA, a 73-amino-acid peptide, is a fluorogenic substrate for ADAMTS13 assay (Ex=340 nm; Em=450 nm) .
loading...
    loading...
Art. -Nr.: HY-153999A
Reinheit:  98.20%
Synonyms: BT200 sodium
Rondaptivon pegol (BT200) sodium is an aptamer targeting von Willebrand factor (VWF), with an EC50 of 33 nM in humans. Rondaptivon pegol sodium effectively alleviates acute myocardial ischemia-reperfusion injury in mice by inhibiting VWF activity, reducing microvascular obstruction, inflammatory responses and cardiomyocyte apoptosis (apoptosis). Rondaptivon pegol sodium inhibits the binding of VWF to platelet glycoprotein GPIb, thereby preventing arterial thrombosis in cynomolgus monkeys. Rondaptivon pegol sodium can be used in research related to arterial thrombosis, stroke, myocardial infarction and myocardial ischemia-reperfusion injury .
loading...
    loading...
Art. -Nr.: HY-138053
CAS. Nr.: 90831-71-3
Synonyms: Ristomycin III
Target:  

Antibiotic

Forschungsgebiete:  

Cardiovascular Disease Infection

Ristocetin A monosulfate (Ristomycin III) is a glycopeptide antibiotic that binds to von Willebrand factor (VWF) and bacterial cell wall components. Ristocetin A (monosulfate) interferes with the biosynthesis of bacterial peptidoglycan by inhibiting transpeptidation. As an inducer of platelet adhesion and aggregation, Ristocetin A (monosulfate) drives conformational changes by binding to the A1 domain of VWF, thereby activating downstream signaling pathways and promoting cytoskeletal rearrangement. Ristocetin A (monosulfate) not only enhances platelet adhesion and spreading on immobilized VWF, but also induces the formation of asymmetric dimers with anticooperativity between platelets and plasma VWF. Ristocetin A (monosulfate) is widely used in studies related to thromboembolic diseases and bacterial infections .
loading...
    loading...
Art. -Nr.: HY-153999
CAS. Nr.: 2573048-75-4
Reinheit:  98.20%
Synonyms: BT200
Rondaptivon pegol (BT200) is an aptamer targeting von Willebrand factor (VWF), with an EC50 of 33 nM in humans. Rondaptivon pegol effectively alleviates acute myocardial ischemia-reperfusion injury in mice by inhibiting VWF activity, reducing microvascular obstruction, inflammatory responses and cardiomyocyte apoptosis (apoptosis). Rondaptivon pegol inhibits the binding of VWF to platelet glycoprotein GPIb, thereby preventing arterial thrombosis in cynomolgus monkeys. Rondaptivon pegol can be used in research related to arterial thrombosis, stroke, myocardial infarction and myocardial ischemia-reperfusion injury .
loading...
    loading...
Art. -Nr.: HY-P99875
CAS. Nr.: 2252477-42-0
Synonyms: BIVV-001; Altuvoct

Target:  

Inhibitory Antibodies

Forschungsgebiete:  

Cardiovascular Disease

Efanesoctocog alfa is a B domain-deleted single-chain Factor VIII (FVIII) connected to D'D3 domain of von Willebrand Factor (vWF). Efanesoctocog alfa has an extended half-life. Efanesoctocog alfa can be used for the study of inherited hemophilia A .
loading...
    loading...
Art. -Nr.: HY-DP5354AF
Target:  

Fluorescent Dye

Forschungsgebiete:  

Others

Biotin-FRETS-VWF73 TFA is a biotin-labeled 73-amino acid peptide. FRETS-VWF73 TFA is a fluorescent substrate for ADAMTS13 detection (Ex=340 nm; Em=450 nm) .
loading...
    loading...
Art. -Nr.: HY-147079A
Reinheit:  92.75%
Synonyms: ARC 1779 sodium
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease

Egaptivon pegol sodium is an aptamer, which blocks binding of the von Willebrand Factor (VWF) to platelet GPIb receptors. Egaptivon pegol sodium has anti-thrombotic efficacy.
loading...
    loading...
Art. -Nr.: HY-147079
CAS. Nr.: 934868-74-3
Synonyms: ARC 1779
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease

Egaptivon pegol (ARC1779) is an aptamer, which blocks binding of the von Willebrand Factor (VWF) to platelet GPIb receptors. Egaptivon pegol has anti-thrombotic efficacy.
loading...
    loading...
BT101 sodium
0 Images
mAmCmAmUmGmUmGmUmCmUmUmAmGmGmUmCmCmCmUmGmGmC‐idT, sodium salt
Art. -Nr.: HY-156501
BT101 (sodium), a complementary aptamer, has been developed to specifically inhibit BT100 function. BT100, a aptamer, inhibits binding of von Willebrand factor (VWF) to platelet glycoprotein GPIb, preventing arterial thrombosis .
loading...
    loading...
Art. -Nr.: HY-P990544
Synonyms: AJW 200; AJvW 2

Target:  

Integrin

Forschungsgebiete:  

Inflammation/Immunology

Anti-vWF Antibody is a humanized antibody expressed in CHO cells that targets vWF. The Anti-vWF Antibody is equipped with huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145.62 kDa. The isotype control for Anti-vWF Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Art. -Nr.: HY-138019
CAS. Nr.: 2088247-61-2
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease

SP-8008 is a selective shear stress-induced platelet aggregation (SIPA) inhibitor with an IC50 of 1.44 μM. SP-8008 effectively interferes von Willebrand factor (vWF) and platelet glycoprotein (GP) Ib interaction. SP-8008 exerts its antithrombotic effect by selectively inhibiting shear stress-induced platelet aggregation .
loading...
    loading...
Art. -Nr.: HY-RS15735
Forschungsgebiete:  

Others

VWF Human Pre-designed siRNA Set A contains three designed siRNAs for VWF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Art. -Nr.: HY-RS17403
Forschungsgebiete:  

Others

Vwf Mouse Pre-designed siRNA Set A contains three designed siRNAs for Vwf gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Art. -Nr.: HY-RS23858
Forschungsgebiete:  

Others

Vwf Rat Pre-designed siRNA Set A contains three designed siRNAs for Vwf gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Art. -Nr.: HY-153998
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease

BT100 (sodium), a aptamer, inhibits binding of von Willebrand factor (VWF) to platelet glycoprotein GPIb, preventing arterial thrombosis .
loading...
    loading...
Art. -Nr.: HY-P82661
Synonyms: VWF; von Willebrand factor; von Willebrand antigen II; F8VWF

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Rat

loading...
    loading...
Art. -Nr.: HY-P82661A
Synonyms: VWF; von Willebrand factor; von Willebrand antigen II; F8VWF

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Rat

loading...
    loading...
Art. -Nr.: HY-P73541
Reinheit:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: VWF; Von Willebrand Factor; F8VWF; Factor VIII Related Antigen; Coagulation Factor VIII VWF; VWD
Species:  
Human
Source:  
CHO
loading...
    loading...